U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07697716) titled 'In Vitro NSCLC EGFR-Mutant Models for Drug Sensitivity Testing' on July 07.
Brief Summary: The PRECISE-EGFR study is a prospective, observational project designed to generate patient-derived in vitro models (cell cultures and organoids) from individuals with non-small cell lung cancer (NSCLC) carrying EGFR mutations. These models will be used to evaluate sensitivity to different anti-EGFR therapies and explore mechanisms of drug resistance.
Using residual biological samples collected during routine clinical practice, the study will not interfere with patient care. Researchers will also compare the molecular characteristics of the m...